These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10738077)

  • 21. Locoregional recurrence of pT3N0M0 breast cancer after mastectomy is not higher than that of pT1-2N0M0: an analysis for radiotherapy.
    Sun JY; Wu SG; Li S; Li FY; Chen WF; Lin Q; He ZY
    Cancer Sci; 2013 May; 104(5):599-603. PubMed ID: 23421381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
    Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
    Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
    Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.
    Turashvili G; Brogi E; Morrow M; Dickler M; Norton L; Hudis C; Wen HY
    BMC Cancer; 2018 Jan; 18(1):42. PubMed ID: 29304773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy.
    Zhao X; Tang Y; Wang S; Yang Y; Fang H; Wang J; Jing H; Zhang J; Sun G; Chen S; Jin J; Song Y; Liu Y; Chen B; Qi S; Li N; Tang Y; Lu N; Ren H; Li Y
    Radiat Oncol; 2020 Sep; 15(1):212. PubMed ID: 32887640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.
    Ragaz J; Jackson SM; Le N; Plenderleith IH; Spinelli JJ; Basco VE; Wilson KS; Knowling MA; Coppin CM; Paradis M; Coldman AJ; Olivotto IA
    N Engl J Med; 1997 Oct; 337(14):956-62. PubMed ID: 9309100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review.
    Frandsen JE; Cannon G; Kokeny KE; Gaffney DK; Matsen C; Wright M; Poppe MM
    Breast J; 2018 Jan; 24(1):7-11. PubMed ID: 28590044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Results of a Highly Performing Conformal Electron Therapy Technique for Chest Wall Irradiation After Mastectomy.
    Grellier Adedjouma N; Chevrier M; Fourquet A; Costa E; Xu H; Berger F; Campana F; Laki F; Beuzeboc P; Lefeuvre D; Fournier-Bidoz N; Kirova YM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):206-214. PubMed ID: 28586961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited Supraclavicular Radiation Field in Breast Cancer With ≥ 10 Positive Axillary Lymph Nodes.
    Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
    Clin Breast Cancer; 2016 Jun; 16(3):e15-21. PubMed ID: 26732519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
    Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
    Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
    Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
    Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
    Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
    Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
    Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Breast carcinoma: value of adjuvant therapy after mastectomy? Overview of personal results over > or = 20 years].
    Schwegler N; Puric E
    Praxis (Bern 1994); 2002 Sep; 91(38):1541-51. PubMed ID: 12369221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: is there a benefit?
    Yadav BS; Sharma SC; George P; Bansal A
    J Cancer Res Ther; 2014; 10(2):279-83. PubMed ID: 25022378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.